Expeditious synthesis, enantiomeric resolution, and enantiomer functional characterization of (4-(4-bromophenyl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline-8-sulfonamide (4BP-TQS): an allosteric agonist-positive allosteric modulator of α7 nicoti
about
Structurally similar allosteric modulators of α7 nicotinic acetylcholine receptors exhibit five distinct pharmacological effects.Critical Molecular Determinants of α7 Nicotinic Acetylcholine Receptor Allosteric Activation: SEPARATION OF DIRECT ALLOSTERIC ACTIVATION AND POSITIVE ALLOSTERIC MODULATION.The activity of GAT107, an allosteric activator and positive modulator of α7 nicotinic acetylcholine receptors (nAChR), is regulated by aromatic amino acids that span the subunit interface.Diverse strategies targeting α7 homomeric and α6β2* heteromeric nicotinic acetylcholine receptors for smoking cessation.Persistent activation of α7 nicotinic ACh receptors associated with stable induction of different desensitized states.1,3-diphenylpropan-1-ones as allosteric modulators of α7 nACh receptors with analgesic and antioxidant properties.The α7 nicotinic receptor dual allosteric agonist and positive allosteric modulator GAT107 reverses nociception in mouse models of inflammatory and neuropathic pain.The interaction between alpha 7 nicotinic acetylcholine receptor and nuclear peroxisome proliferator-activated receptor-α represents a new antinociceptive signaling pathway in mice.New Insights on Neuronal Nicotinic Acetylcholine Receptors as Targets for Pain and Inflammation: A Focus on α7 nAChRs.Nicotinic acetylcholine receptors in neuropathic and inflammatory pain.
P2860
Q35055568-82869C12-1044-47FC-BDFE-2EF281376E0AQ36650296-279FB0CE-09AD-4565-A409-2AE7116A12E4Q37583624-7B3748D5-9BFE-400A-BFDF-5E0171433A72Q38204497-12FAB2EC-0E31-4F5A-9BB0-CF0DEBE4533EQ38801002-E9AA3F7C-2D02-4206-BD12-8D2C5DB52CB1Q38869450-5CA59FC8-8640-47CE-ADCB-142E78ECD7B1Q42406043-9497D794-DE7B-48A7-A6C9-D65CC7211DC9Q45061221-CB39F0BA-28EE-49B4-9440-25E082758B5EQ45065606-16F1C92A-0F95-45B3-99BB-D3607527251DQ47739924-1CF23682-3FB1-4FC3-AF4E-130A8CF7566B
P2860
Expeditious synthesis, enantiomeric resolution, and enantiomer functional characterization of (4-(4-bromophenyl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline-8-sulfonamide (4BP-TQS): an allosteric agonist-positive allosteric modulator of α7 nicoti
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Expeditious synthesis, enantio ...... osteric modulator of α7 nicoti
@en
Expeditious synthesis, enantio ...... osteric modulator of α7 nicoti
@nl
type
label
Expeditious synthesis, enantio ...... osteric modulator of α7 nicoti
@en
Expeditious synthesis, enantio ...... osteric modulator of α7 nicoti
@nl
prefLabel
Expeditious synthesis, enantio ...... osteric modulator of α7 nicoti
@en
Expeditious synthesis, enantio ...... osteric modulator of α7 nicoti
@nl
P2093
P2860
P356
P1476
Expeditious synthesis, enantio ...... osteric modulator of α7 nicoti
@en
P2093
Abhijit R Kulkarni
Ganesh A Thakur
Roger L Papke
P2860
P304
P356
10.1021/JM401267T
P407
P577
2013-10-25T00:00:00Z